AGL 38.90 Increased By ▲ 0.64 (1.67%)
AIRLINK 138.51 Decreased By ▼ -2.49 (-1.77%)
BOP 5.40 Decreased By ▼ -0.04 (-0.74%)
CNERGY 3.83 Decreased By ▼ -0.01 (-0.26%)
DCL 7.64 Increased By ▲ 0.04 (0.53%)
DFML 47.60 Increased By ▲ 1.41 (3.05%)
DGKC 78.10 Increased By ▲ 0.60 (0.77%)
FCCL 29.10 Decreased By ▼ -0.18 (-0.61%)
FFBL 57.05 Increased By ▲ 0.55 (0.97%)
FFL 8.70 Increased By ▲ 0.10 (1.16%)
HUBC 100.50 Increased By ▲ 1.81 (1.83%)
HUMNL 15.08 Increased By ▲ 0.98 (6.95%)
KEL 3.89 Increased By ▲ 0.06 (1.57%)
KOSM 7.62 Increased By ▲ 0.23 (3.11%)
MLCF 37.02 Increased By ▲ 0.32 (0.87%)
NBP 68.30 Decreased By ▼ -0.60 (-0.87%)
OGDC 169.80 Increased By ▲ 0.30 (0.18%)
PAEL 25.80 Increased By ▲ 0.40 (1.57%)
PIBTL 6.55 Decreased By ▼ -0.01 (-0.15%)
PPL 132.25 Increased By ▲ 1.25 (0.95%)
PRL 25.43 Increased By ▲ 0.32 (1.27%)
PTC 15.80 Increased By ▲ 0.16 (1.02%)
SEARL 61.20 Increased By ▲ 3.20 (5.52%)
TELE 7.02 Increased By ▲ 0.12 (1.74%)
TOMCL 36.11 Increased By ▲ 0.87 (2.47%)
TPLP 7.65 Decreased By ▼ -0.08 (-1.03%)
TREET 14.06 Decreased By ▼ -0.04 (-0.28%)
TRG 45.30 Increased By ▲ 0.61 (1.36%)
UNITY 25.71 Increased By ▲ 0.30 (1.18%)
WTL 1.22 Increased By ▲ 0.01 (0.83%)
BR100 9,193 Increased By 41.5 (0.45%)
BR30 27,437 Increased By 203 (0.75%)
KSE100 86,388 Increased By 547.4 (0.64%)
KSE30 27,312 Increased By 77.6 (0.29%)

Karachi: The Drug Regulatory Authority of Pakistan (DRAP) in Wednesday agreed to increase price of Paracetamol tablets from Rs. 1.90 per tablet to Rs 2.65 per tablet, sources privy to the development told Business Recorder.

In this regard, the sources explained, a summary would be forwarded to federal cabinet for approval. Former chairman Pakistan Pharmaceutical Manufact-urers Association (PPMA) Dr Kaiser Waheed said Paracetamol availability was disturbed for a short period due to non-availability of basic ingredients to manufacture its active raw material

He informed that some of the factories, producing active ingredient of in china, were closed down due to certain reasons. Noteworthy to mention here that, Pakistan is facing extreme shortage of various brands of Paracetamol at the moment amid Covid-19 third wave and growing dengue, typhoid and malaria cases.

Copyright Business Recorder, 2022

Comments

Comments are closed.